0.2393
0.0000
(0.00%)
As of January 30 at 3:00:00 PM EST. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-144,162.0000
-144,162.0000
-202,464.0000
-146,930.0000
-84,911.0000
Investing Cash Flow
149,845.0000
149,845.0000
-1,148,383.0000
-274,492.0000
132,297.0000
Financing Cash Flow
-81,496.0000
-81,496.0000
-1,419.0000
-31,098.0000
-21,670.0000
End Cash Position
330,117.0000
330,117.0000
403,768.0000
1,727,411.0000
2,210,504.0000
Capital Expenditure
-19,158.0000
-19,158.0000
-14,401.0000
-7,198.0000
-38,960.0000
Issuance of Capital Stock
--
--
961.0000
--
--
Repurchase of Capital Stock
-78,961.0000
-78,961.0000
--
-28,689.0000
-19,601.0000
Free Cash Flow
-163,320.0000
-163,320.0000
-216,865.0000
-154,128.0000
-123,871.0000
12/31/2020 - 11/19/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
1BT.F Enlivex Therapeutics Ltd.
1.0500
0.00%
BOVNF BioInvent International AB (publ)
4.7000
0.00%
GYX.F Futura Medical plc
0.1750
-50.00%
F6T.MU Fate Therapeutics Inc
1.2810
0.00%
1GDA.F Zevra Therapeutics, Inc.
7.65
+2.68%
GNNSF Genscript Biotech Corporation
1.3550
0.00%
VBIZF Viva Biotech Holdings
0.0950
0.00%
CVAC.VI CureVac N.V.
3.7140
-1.17%
HQ1.MU Oruka Therapeutics Inc. R
12.00
+5.26%
SNBIF SanBio Company Limited
4.6500
0.00%